Patents by Inventor Daniel Oberg

Daniel Oberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12013348
    Abstract: There is presented a system and method for detecting mobile device fault conditions, particularly detecting defects in a display or housing of a mobile device. One or more cameras included within the mobile device are used with a reflecting surface in a test fixture to obtain properly aligned and formatted images of the external housing and display of the mobile device, and interactive guidance assists with placement and execution of diagnostics. A remote server conducts further analysis of the captured images, and then defect status may be returned to and displayed upon the mobile device screen.
    Type: Grant
    Filed: October 22, 2020
    Date of Patent: June 18, 2024
    Assignee: BLANCCO TECHNOLOGY GROUP IP OY
    Inventors: William Fitzgerald, Daniel Öberg, Patrick Conway, Donal O'Shaughnessy, Donie Kelly, Tero Mononen
  • Publication number: 20230409510
    Abstract: There are provided systems and methods for mobile device diagnostics and provisioning, whereby connections are effectuated to communicate directly with hardware of mobile devices to perform diagnostics and other functions such as device erasure without the need to first install an app on the mobile device. In this manner, information such as detailed product identification, vendor identification, and diagnostic information may be quickly obtained from the mobile device, and diagnostics and erasure undertaken to return a previously owned device into the stream of commerce in an efficient manner.
    Type: Application
    Filed: August 23, 2023
    Publication date: December 21, 2023
    Inventors: Jonathan Villareal, Russ B. Ernst, Daniel Oberg, Markus Torma, Tomi Lehtola
  • Patent number: 11748296
    Abstract: There are provided systems and methods for mobile device diagnostics and provisioning, whereby connections are effectuated to communicate directly with hardware of mobile devices to perform diagnostics and other functions such as device erasure without the need to first install an app on the mobile device. In this manner, information such as detailed product identification, vendor identification, and diagnostic information may be quickly obtained from the mobile device, and diagnostics and erasure undertaken to return a previously owned device into the stream of commerce in an efficient manner.
    Type: Grant
    Filed: September 14, 2020
    Date of Patent: September 5, 2023
    Assignee: BLANCCO TECHNOLOGY GROUP IP OY
    Inventors: Jonathan Villareal, Russ B. Ernst, Daniel Öberg, Markus Törmä, Tomi Lehtola
  • Publication number: 20220164772
    Abstract: According to an aspect, there is provided a method for guiding a user of a first computing device in selecting a suitable erasure process for a second computing device. Initially, information on a plurality of erasure reports describing erasure processes carried out for computing devices is maintained in an erasure report database. A remote computing device receives one or more device parameters characterizing the second computing device from the first computing device. The remote computing system compares the one or more device parameters to device parameters maintained in the erasure report database in response to the receiving and based thereon determines one or more expected erasure process properties for at least one erasure process for erasing a memory or part thereof of the second computing device. The remote computing system sends the one or more expected erasure process properties for said at least one erasure process to the first computing device.
    Type: Application
    Filed: January 29, 2020
    Publication date: May 26, 2022
    Applicant: Blancco Technology Group IP Oy
    Inventors: Mikko Fabritius, Daniel Oberg, Russ Ernst
  • Publication number: 20210116392
    Abstract: There is presented a system and method for detecting mobile device fault conditions, particularly detecting defects in a display or housing of a mobile device. One or more cameras included within the mobile device are used with a reflecting surface in a test fixture to obtain properly aligned and formatted images of the external housing and display of the mobile device, and interactive guidance assists with placement and execution of diagnostics. A remote server conducts further analysis of the captured images, and then defect status may be returned to and displayed upon the mobile device screen.
    Type: Application
    Filed: October 22, 2020
    Publication date: April 22, 2021
    Inventors: William FITZGERALD, Daniel ÖBERG, Patrick CONWAY, Donal O'SHAUGHNESSY, Donie KELLY, Tero MONONEN
  • Publication number: 20210081351
    Abstract: There are provided systems and methods for mobile device diagnostics and provisioning, whereby connections are effectuated to communicate directly with hardware of mobile devices to perform diagnostics and other functions such as device erasure without the need to first install an app on the mobile device. In this manner, information such as detailed product identification, vendor identification, and diagnostic information may be quickly obtained from the mobile device, and diagnostics and erasure undertaken to return a previously owned device into the stream of commerce in an efficient manner.
    Type: Application
    Filed: September 14, 2020
    Publication date: March 18, 2021
    Inventors: Jonathan Villareal, Russ B. Ernst, Daniel Öberg, Markus Törmä, Tomi Lehtola
  • Patent number: 10738283
    Abstract: The invention relates to a recombinant adenovirus that has an oncolytic effect in a cancer cell. By modulating the level and type of splice isoforms of the E1B gene product, expressed from the E1B gene, the oncolytic activity of such viruses can be enhanced. The invention provides a recombinant adenovirus in which the proportion of the E1B-156R isoform is increased relative to wild-type levels. Such a recombinant adenovirus may selectivity replicate in cancer cells, thereby killing cancer cells whilst sparing normal cells.
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: August 11, 2020
    Assignee: Ixogen Ltd.
    Inventor: Hans Daniel Öberg
  • Patent number: 10719261
    Abstract: Disclosed herein is a method for providing for erasure of data from, and/or diagnosis of at least one condition of a device. The method includes the steps of providing a stored set of actions, the actions directed to either or both of an erasure action and a diagnosis action; selecting actions from the stored set and linking the actions to generate a sequence of actions; and outputting, storing or performing the generated sequence of actions. Performing the sequence of actions may include performing at least one of the actions in dependence or based on data representative of a property of the device, at least one customer or client or business preference or requirement, or at least one regulatory requirement.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: July 21, 2020
    Assignee: BLANCCO TECHNOLOGY GROUP IP OY
    Inventors: Markus Törmä, Daniel Öberg
  • Publication number: 20190354298
    Abstract: A method for use in repurposing, erasing data from, and/or disposing of an IT asset comprises transmitting a signal, for example an erasure target signal, from the IT asset to a server located remotely from the IT asset, receiving at the server at least part of a profile of the IT asset, and in response to receipt of the signal, for example the erasure target signal, at the server, identifying an action to be performed in relation to the IT asset based at least in part on the profile or part of the profile of the IT asset. The method may comprise transmitting instructions from the server to an erasure client, which instructions at least partially define the action to be performed in relation to the IT asset and in response to receipt of the instructions at the erasure client, performing the action in relation to the IT asset. The action to be performed may comprise an erasure procedure.
    Type: Application
    Filed: November 17, 2017
    Publication date: November 21, 2019
    Applicant: Blancco Technology Group IP Oy
    Inventors: Daniel ÖBERG, Tom REID, Väinö LEPPÄNEN, Irina PIROGOVA
  • Publication number: 20190095126
    Abstract: Disclosed herein is a method for providing for erasure of data from, and/or diagnosis of at least one condition of a device. The method includes the steps of providing a stored set of actions, the actions directed to either or both of an erasure action and a diagnosis action; selecting actions from the stored set and linking the actions to generate a sequence of actions; and outputting, storing or performing the generated sequence of actions. Performing the sequence of actions may include performing at least one of the actions in dependence or based on data representative of a property of the device, at least one customer or client or business preference or requirement, or at least one regulatory requirement.
    Type: Application
    Filed: September 21, 2018
    Publication date: March 28, 2019
    Inventors: Markus Törmä, Daniel Öberg
  • Publication number: 20180371425
    Abstract: The invention relates to a recombinant adenovirus that has an oncolytic effect in a cancer cell. By modulating the level and type of splice isoforms of the E1B gene product, expressed from the E1B gene, the oncolytic activity of such viruses can be enhanced. The invention provides a recombinant adenovirus in which the proportion of the E1B-156R isoform is increased relative to wild-type levels. Such a recombinant adenovirus may selectivity replicate in cancer cells, thereby killing cancer cells whilst sparing normal cells.
    Type: Application
    Filed: July 9, 2018
    Publication date: December 27, 2018
    Inventor: Hans Daniel Öberg
  • Patent number: 10047347
    Abstract: The invention relates to a recombinant adenovirus that has an oncolytic effect in a cancer cell. By modulating the level and type of splice isoforms of the E1B gene product, expressed from the E1B gene, the oncolytic activity of such viruses can be enhanced. The invention provides a recombinant adenovirus in which the proportion of the E1B-156R isoform is increased relative to wild-type levels. Such a recombinant adenovirus may selectivity replicate in cancer cells, thereby killing cancer cells while sparing normal cells.
    Type: Grant
    Filed: November 29, 2013
    Date of Patent: August 14, 2018
    Assignee: Ixogen Ltd.
    Inventor: Hans Daniel Öberg
  • Publication number: 20150315547
    Abstract: The invention relates to a recombinant adenovirus that has an oncolytic effect in a cancer cell. By modulating the level and type of splice isoforms of the E1B gene product, expressed from the E1B gene, the oncolytic activity of such viruses can be enhanced. The invention provides a recombinant adenovirus in which the proportion of the E1B-156R isoformis increased relative to wild-type levels. Such a recombinant adenovirus may selectivity replicate in cancer cells, thereby killing cancer cells whilst sparing normal cells.
    Type: Application
    Filed: November 29, 2013
    Publication date: November 5, 2015
    Applicant: Ixogen Ltd.
    Inventor: Hans Daniel Öberg